What is Topicals?
Founded in 2010, Topicals is a skincare company dedicated to developing solutions for chronic skin issues such as eczema, hyperpigmentation, and psoriasis. The brand has established a strong retail presence, notably through Sephora, positioning itself as a key player in the consumer dermatology market. The recent enterprise-level funding indicates a strategic push for scaling operations and expanding market reach.
How much funding has Topicals raised?
Topicals has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2022): $10M with participation from Cavu Consumers Partners
Key Investors in Topicals
Cavu Consumers Partners
Cavu Consumers Partners is an investment firm that likely focuses on consumer-facing brands and retail innovations, providing strategic capital to companies with strong market potential.
What's next for Topicals?
With a substantial funding round, Topicals is poised for accelerated growth. This capital injection is expected to fuel product development, enhance marketing initiatives, and potentially expand its distribution channels. The company's focus on scientifically-backed solutions for common dermatological concerns suggests a trajectory towards becoming a leader in the specialized skincare sector. Future developments will likely center on deepening its product portfolio and solidifying its brand authority in the competitive beauty and wellness industry.
See full Topicals company page
